SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0000930413-18-003223
Filing Date
2018-10-30
Accepted
2018-10-30 16:02:39
Documents
4

Document Format Files

Seq Description Document Type Size
1 c92219_424b5.htm 424B5 397670
2 GRAPHIC x1_c92219a001.jpg GRAPHIC 14003
3 GRAPHIC x1_c92219a002.jpg GRAPHIC 138928
4 GRAPHIC x1_c92115x4x1.jpg GRAPHIC 4440
  Complete submission text file 0000930413-18-003223.txt   608418
Mailing Address 4150 ST CATHERINE STREET WEST SUITE 550 MONTREAL A8 H3Z 2Y5
Business Address 4150 ST CATHERINE STREET WEST SUITE 550 MONTREAL A8 H3Z 2Y5 (514) 940-3600
Clementia Pharmaceuticals Inc. (Filer) CIK: 0001647320 (see all company filings)

IRS No.: 981128564 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-227726 | Film No.: 181146951
SIC: 2834 Pharmaceutical Preparations